Table 1.
Characteristic | RSV (n = 153) | hMPV (n = 19) | HRV (n = 59) | PIV1‐3 (n = 20) | IFVA (n = 14) | AdV (n = 23) | HBoV (n = 19) | p |
---|---|---|---|---|---|---|---|---|
No. (%) of patients with coinfectiona | 178 (55.78%) | 31 (62%) | 103 (63.59%) | 44 (68.75%) | 44 (75.86%) | 38 (62.29%) | 75 (79.79%) | <0.01b,c |
Age (months) | ||||||||
Median (range) | 9 (0.03–144) | 11 (0.58–108) | 8 (0.2–132) | 9.5 (0.6–96) | 9 (0.03–168) | 18 (0.03–108) | 14.5 (0.1–108) | |
Sex | ||||||||
Male:female | 94:59 | 13:6 | 33:26 | 12:8 | 7:7 | 19:4 | 14:5 | >0.01c |
Clinical diagnosis | ||||||||
Pneumonia | 77 (50.3) | 13 (68.4) | 38 (61.0) | 8 (40) | 11 (78.6) | 18 (78.3) | 10 (52.6) | |
Bronchitis | 8 (5.2) | 1 (5.3) | 1 (1.7) | 4 (20) | 3 (21.4) | 1 (4.3) | 4 (21.1) | |
Bronchiolitis | 68 (44.4) | 5 (26.3) | 20 (33.9) | 8 (40) | 0 (0) | 4 (17.4) | 5 (26.3) |
aEpisodes of coinfection with >1 virus were excluded from the analysis of demographic and clinical diagnosis.
bCoinfection rates of HBoV and IFVA were higher than those of RSV.
cCalculated using the Chi‐square test.